Professor Anthony Gill AM is Professor of Surgical Pathology at the University of Sydney, a senior staff specialist in anatomical pathology at the Royal North Shore Hospital in Sydney and chairman of the Australian Pancreatic Genome Initiative (APGI). His scope of clinical practice includes both anatomical (surgical and cytological) pathology and targeted molecular testing of tumours, with an emphasis on biomarker development and companion diagnostic testing for targeted therapies.
In addition to his clinical practice, he has a proven track record of translating advances in the knowledge of cancer gained at the basic science level into validated and clinically useful tests which are now employed in diagnostic pathology laboratories around the world. He has co-authored over 500 highly cited original research publications in addition to numerous invited review articles and book chapters. He is a standing editorial board member of the WHO/IARC classification of tumours which is considered the peak international body in surgical pathology and sets diagnostic criteria for tumours applied around the world. In 2018 he was appointed a member of the order of Australia (AM) in the Queens Birthday honours list “for significant service to medical research in the field of surgical pathology as an academic, author; adviser, and mentor”.
Skip to content
Skip to site navigation
Skip to local navigation
Medical Services Advisory Committee